The heart in cases of viral, bacterial and parasitic infections;Das herz bei viralen, bakteriellen und parasitären infektionen

Internist

Volumn 48, Issue 3, 2007, Pages 255-267

  Maisch, B ^a,b   Alter, P ^a   Karatolius, K ^a   Ruppert, V ^a   Pankuweit, S ^a  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

^b UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

Bacteria; Endocarditis; Myocarditis; Parasites; Pericarditis; Viruses

Indexed keywords

ACETYLSALICYLIC ACID; AMINOGLYCOSIDE; ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; ANTIVIRUS AGENT; AZATHIOPRINE; AZITHROMYCIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA INTERFERON; CEFOTAXIME; CEFUROXIME; CISPLATIN; COLCHICUM EXTRACT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GENTAMICIN; IMIPENEM; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; INTERFERON; MEROPENEM; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN G; PREDNISONE; RIFAMPICIN; TEICOPLANIN; TRIAMCINOLONE; UNINDEXED DRUG; VANCOMYCIN;

ANTIBODY SPECIFICITY; B LYMPHOCYTE; BACTERIAL INFECTION; CARDIOMYOPATHY; CORONARY ARTERY DISEASE; DISEASE CLASSIFICATION; ENDOCARDITIS; HEART; HEART DISEASE; HEART MUSCLE; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MACROPHAGE; MONOCYTE; MYOCARDITIS; PARASITOSIS; PATHOGENESIS; PATHOPHYSIOLOGY; PERICARDITIS; PERICARDIUM; PRACTICE GUIDELINE; REVIEW; T LYMPHOCYTE; VIRUS INFECTION; VIRUS MYOCARDITIS;

BACTERIAL INFECTIONS; CARDIOMYOPATHIES; CORONARY ARTERIOSCLEROSIS; ENDOCARDITIS, BACTERIAL; ENDOCARDIUM; HUMANS; MAGNETIC RESONANCE IMAGING; MYOCARDITIS; MYOCARDIUM; PARASITIC DISEASES; PERICARDITIS; PERICARDIUM; VIRUS DISEASES;

EID: 33847717500     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-006-1775-8     Document Type: Review

References (34)

1. Alter P, Hoeschen J, Ritter M et al. (2002) Usefulness of cytokines interleukin-6 and interleukin-2R concentrations in diagnosing active infective endocarditis involving native valves. Am J Cardiol 89: 1400-1404
2. Bayer AS (1993) Infective endocarditis. Clin Infect Dis 17: 313-320
3. Bonow RO, Carabello BA, Kanu C et al. (2006) ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 114: e84-231
4. Butchart EG, Gohlke-Barwolf C, Antunes MJ et al. (2005) Recommendations for the management of patients after heart valve surgery. Eur Heart J 26: 2463-2471
5. Calabrese F, Thiene G (2003) Myocarditis and inflammatory cardiomyopathy: microbiological and molecular biological aspects. Cardiovasc Res 60: 11-25
6. Feldmann AM, McNamara D(2000) Myocarditis. N Eng J Med 343: 1388-1392
7. Durack DT, Lukes AS, Bright DK (1994) New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 96: 200-209
8. Fowler VG Jr, Miro JM, Hoen B et al. (2005) Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 293: 3012-3021
9. Horstkotte D, Follath F, Gutschik E et al. (2004) Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology. Eur Heart J 25: 267-276
10. Hunt SA, Baker DW, Chin MH et al.; American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure); International Society for Heart and Lung Transplantation; Heart Failure Society of America (2001) ACC/AHA Guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. Circulation 104, 2996-3007
11. Imazio M, Bobbio M, Cecchi E et al. (2005) Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation 112: 2012-2016
12. Koegelenberg CF, Doubell AF, Orth H et al. (2003) Infective endocarditis in the Western Cape Province of South Africa: a three-year prospective study. QJM 96: 217-225
13. Maisch B (Hrsg) (1987) Infektiöse Endokarditis. Perimed, Erlangen
14. Maisch B (1989) Klinische Aspekte der infektiösen Endokarditis. Internist 30: 483-491
15. Maisch B (2003) Entzündliche Herzerkrankungen (Endokarditis, Myokarditis und Kardiomyopathien). In: Claasen M, Diehl V, Kochsiek K et al. (Hrsg) Innere Medizin. Urban und Schwarzenberg, München, S1156-1166
16. Maisch B, Karatolios K, Pankuweit S (2006) Rezidivierender autoreaktiver Perikarderguss: Bedeutung einer ätiologischen Klassifikation der Perikarditis. Dtsch Med Wochenschr 131: 2143-2146
17. Maisch B, Kölsch S, Hufnagel G et al. (2006) The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID): intermediate results of immunosuppressive therapy. Circulation 114 (Suppl 2), II-620 (A2950)
18. Maisch B. Pankuweit S, Funck R et al. (2005) "Auf den Zahn gefühlt" bei kardiovaskulären Erkrankungen. Herz 30: 669-674
19. Maisch B, Pankuweit S, Karatolios K et al. (2006) Invasive techniques - form diagnosis to treatment. Rheumatology 45 (Suppl 4): iv32-iv38
20. Maisch B, Portig I, Ristic AD et al. (2000) Definition of inflammatory cardiomyopathy (myocarditis): on the way to consensus - a status report. Herz 25: 200-209
21. Maisch B, Richter A, Sandmöller A et al. (2005) Inflammatory dilated cardiomyopathy (DCMI). Herz 30: 535-544
22. Maisch B, Ristic AD, Pankuweit S (2002) Intrapericardial treatment of autoreactive pericardial effusion with triamcinolone; the way to avoid side effects of systemic corticosteroid therapy. Eur Heart J 23: 1503-1508
23. Maisch B, Seferovic PM, Ristic AD et al.; Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (2004) Guidelines on the diagnosis and management of pericardial diseases: executive summary. Eur Heart J 25: 587-610
24. Maisch B, Soler-Soler J, Hatle L et al. (2006) Pericardial diseases. In: Serruys PW, Camm AJ, Lüscher TF (Eds) The ESC textbook of cardiovascular medicine. Blackwell, London, pp 517-534
25. Maron BJ, Towbin JA, Thiene G et al. (2006) Contemporary definitions and classification of the cardiomyopathies. An American Heart Association scientific statement from the council on clinical cardiology, heart failure and transplanatatio committee, quality of care and coutcomes research and functional genomics and translational biology interdisciplinary working groups; and council on epidemiology and prevention. Circulation 113: 1807-1616
26. Mylonakis E, Calderwood SB (2001) Infective endocarditis in adults. N Engl J Med 345: 1318-1330
27. Pankuweit S, Baandrup U, Moll R et al. (2003) Prevalence of Parvovirus B 19 genome in endomyocardial biopsy specimen. Hum Pathol 34: 80-86
28. Prata A (2001) Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis 1: 92-100
29. Richardson P, McKenna W, Bristow M et al. (1996) Reportof the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 93: 841-842
30. Roe MT, Abramson MA, Li J et al. (2000) Clinical information determines the impact of transesophageal echocardiography on the diagnosis of infective endocarditis by the Duke criteria. Am Heart J 139: 945-951
31. Scheffold N, Sucker C, Bergler-Klein J et al. (2000). Akute Myokarditis und Kardiomyopathie bei der Lyme-Borreliose. Z Kardiol 11: 1046-1052
32. Werner M, Andersson R, Olaison L et al. (2003) A clinical study of culture-negative endocarditis. Medicine 82: 263-273
33. Zahn R, Schneider S, Frilling B et al. (2003) Antibiotic therapy after acute myocardial infarction. Circulation 107: 1253-1259
34. Zamorano J, Sanz J, Almeria C et al. (2003) Differences between endocarditis with true negative blood cultures and those with previous antibiotic treatment. J Heart Valve Dis 12: 256-260